Tanezumab (CAS 880266-57-9) Market Research Report 2025 '@aboutTanezumab is a monoclonal antibody against nerve growth factor (NGF), with a molecular formula of C6464H9942N1706O2026S46. It was developed by the American corporation Pfizer as a pain mediator. Tanezumab is used to reduce pain in joints and ...